Sponsor pipeline

Emergent BioSolutions clinical trial pipeline

Get alerts when Emergent BioSolutions's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 4
2
Not charted: 5 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT02177721 Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational… Infections, Bacterial Not Yet Recruiting 2026-02-06
NCT02051062 BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients Botulism Enrolling by Invitation 2026-01-16
Not specified
NCT01374984 VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or… Complication of Smallpox Vaccination Enrolling by Invitation 2026-05-12
NCT07478471 Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax Infections, Bacterial Not Yet Recruiting 2026-03-17
NCT03569514 Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in… Anthrax Not Yet Recruiting 2026-02-06
NCT03569553 A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in… Inhalational Anthrax Not Yet Recruiting 2026-02-06
NCT07268612 Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for… Anthrax Not Yet Recruiting 2025-12-08
Get alerts when Emergent BioSolutions's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free